Just diagnosed with Segmental arterial mediolysis?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Segmental arterial mediolysis, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Segmental arterial mediolysis hub →Overview
Segmental arterial mediolysis is a rare condition. Tomeko brings together the specialists, research, clinical trials, treatments and community for Segmental arterial mediolysis so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:645350 · ICD-10 I77.8 · GARD 0026833
Find care for Segmental arterial mediolysis
Authoritative references for Segmental arterial mediolysis
Research & market landscape for Segmental arterial mediolysis
Following Segmental arterial mediolysis for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Segmental arterial mediolysis — the real-world landscape behind the condition, in one place.
- Latest Segmental arterial mediolysis research on PubMed ↗
- Recruiting Segmental arterial mediolysis trials on ClinicalTrials.gov ↗
- Explore the Segmental arterial mediolysis research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Segmental arterial mediolysis and every rare condition. See how Tomeko works with industry →
Common questions
What is Segmental arterial mediolysis?
Segmental arterial mediolysis is a rare condition. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Segmental arterial mediolysis together in one place.
What are the symptoms of Segmental arterial mediolysis?
Symptoms of Segmental arterial mediolysis vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Segmental arterial mediolysis.
How is Segmental arterial mediolysis treated?
Treatment for Segmental arterial mediolysis depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Segmental arterial mediolysis, and review current options with them.
What causes Segmental arterial mediolysis — is it genetic?
The cause and inheritance of Segmental arterial mediolysis are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Segmental arterial mediolysis can explain what it means for you and your family.
I was just diagnosed with Segmental arterial mediolysis — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Segmental arterial mediolysis, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Segmental arterial mediolysis?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Segmental arterial mediolysis, filtered to your area.
Are there clinical trials for Segmental arterial mediolysis?
Tomeko shows live, recruiting studies for Segmental arterial mediolysis from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- Acquired aneurysmal subarachnoid hemorrhage
- Arrhythmogenic cardiomyopathy with wooly hair and keratoderma
- Arterial dissection-lentiginosis syndrome
- Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome
- Atrophic papulosis
- Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
- Autosomal recessive leukoencephalopathy-ischemic stroke-retinitis pigmentosa syndrome
- Brugada syndrome